chr3-68977627-A-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001278689.2(EOGT):āc.1575T>Gā(p.Asp525Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00123 in 1,613,752 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001278689.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EOGT | NM_001278689.2 | c.1575T>G | p.Asp525Glu | missense_variant | 18/18 | ENST00000383701.8 | NP_001265618.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EOGT | ENST00000383701.8 | c.1575T>G | p.Asp525Glu | missense_variant | 18/18 | 1 | NM_001278689.2 | ENSP00000373206.3 |
Frequencies
GnomAD3 genomes AF: 0.000657 AC: 100AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000562 AC: 141AN: 250926Hom.: 0 AF XY: 0.000472 AC XY: 64AN XY: 135598
GnomAD4 exome AF: 0.00129 AC: 1883AN: 1461532Hom.: 2 Cov.: 31 AF XY: 0.00123 AC XY: 892AN XY: 727048
GnomAD4 genome AF: 0.000657 AC: 100AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.000403 AC XY: 30AN XY: 74374
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 08, 2024 | The c.1323T>G (p.D441E) alteration is located in exon 15 (coding exon 12) of the EOGT gene. This alteration results from a T to G substitution at nucleotide position 1323, causing the aspartic acid (D) at amino acid position 441 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Adams-Oliver syndrome 4 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 19, 2022 | This sequence change replaces aspartic acid, which is acidic and polar, with glutamic acid, which is acidic and polar, at codon 441 of the EOGT protein (p.Asp441Glu). This variant is present in population databases (rs140481649, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with EOGT-related conditions. ClinVar contains an entry for this variant (Variation ID: 1483956). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at